NPC searching for president: Norris resigns Feb. 26; previous candidates may be re-approached.
NATIONAL PHARMACEUTICAL COUNCIL SEARCHING FOR NEW PRESIDENT following the Feb. 26 departure of ex-FDA Deputy Commissioner John Norris after less than 10 months with the association. The precipitous nature of the change was highlighted by the description of the transition management. Until a successor is found, NPC said in a short statement, "NPC's senior staff will collectively manage the association, under the direction of the board."
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth